Described herein are pharmaceutical packaging units which protect against oxidative degradation of morphine, hydromorphone, promethazine and also other oxygen-delicate drugs, these systems including a syringe having an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with incredibly minimal permeability to oxygen an